Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

AcelRx pain drug shows mixed results in mid-stage trial
Reuters
Wednesday, April 24, 2013 - 10:20am
tags:
AcelRx, painkillers
Aveo's Inflection Point: Tivozanib Likely To Receive Positive Advisory Vote, FDA Approval
Seeking Alpha
Wednesday, April 24, 2013 - 10:19am
tags:
Aveo Pharmaceuticals, FDA, tivozanib, GSK, Onyx, Pfizer, renal cell carcinoma, Roche
The Medicines Company Reports First Quarter 2013 Financial Results
Yahoo
Wednesday, April 24, 2013 - 9:41am
tags:
earnings, Medicines Company
An Undervalued Pharmaceutical Company With Remarkable Results
Seeking Alpha
Wednesday, April 24, 2013 - 9:40am
tags:
Teva
For Iluvien, The FDA Isn't The Issue; European Sales Are
Seeking Alpha
Wednesday, April 24, 2013 - 9:37am
tags:
FDA, Iluvien, DME, diabetic macular edema, pSivida, Alimera
Eli Lilly Profit Beats Estimates on Lower Costs
Bloomberg
Wednesday, April 24, 2013 - 9:35am
tags:
earnings, Eli Lilly
Merck's lambrolizumab designated by the the FDA as Breakthrough Therapy
Yahoo/AP
Wednesday, April 24, 2013 - 9:34am
tags:
Merck, lambrolizumab, FDA, MK-3475, melanoma
Novartis posts profit gain thanks to new drugs
Yahoo/AP
Wednesday, April 24, 2013 - 9:33am
tags:
earnings, Novartis
Boehringer anti-clotting pill gains blockbuster status
Reuters
Wednesday, April 24, 2013 - 8:47am
tags:
anticoagulants, Boehringer Ingelheim, Pradaxa
Elan sees sales of prized Tysabri drug rise sharply
Reuters
Wednesday, April 24, 2013 - 8:46am
tags:
Elan, Royalty Pharma, M&A, Tysabri
US Sues Novartis Over Alleged Fraudulent Kickbacks
CNBC/Reuters
Wednesday, April 24, 2013 - 8:44am
tags:
Novartis, kickbacks, Myfortic
Melanoma: Battle Of 3 Cancer Vaccines
Seeking Alpha
Tuesday, April 23, 2013 - 3:31pm
tags:
melanoma, vaccines, Amgen, Celldex, Oncothyreon, OncoSec, Vical
Aragon Pharma's ARN-509 Is No Near-Term Threat to Medivation
Yahoo/Minyanville
Tuesday, April 23, 2013 - 3:30pm
tags:
Medivation, Aragon, ARN-509, prostate cancer
3 Giant Drug Earnings Wed.: Glaxo, Lilly, Novartis
Investors.com
Tuesday, April 23, 2013 - 3:27pm
tags:
earnings, Novartis, Eli Lilly, GSK
Astrazeneca Earnings Preview: Can This Streak Continue?
Wall St. Cheat Sheet
Tuesday, April 23, 2013 - 3:27pm
tags:
earnings, AstraZeneca
Many Biotechs Fail To Embrace Reimbursement Issues
Pharmalot
Tuesday, April 23, 2013 - 11:36am
tags:
biotech, reimbursement
5 Top Biotechs With Bolting Stocks, Earnings On Tap
Investors.com
Tuesday, April 23, 2013 - 11:34am
tags:
earnings, Medicines Company, Celgene, Gilead, Amgen, Biogen Idec
Illumina Jumps Most in 15 Months on First-Quarter Profit
Bloomberg
Tuesday, April 23, 2013 - 11:31am
tags:
earnings, Illumina
FDA Scolds Teva For An Unbalanced And Overblown Handout
Pharmalot
Tuesday, April 23, 2013 - 11:23am
tags:
FDA, Teva, clozapine
Bristol Still Playing Catch-Up To Gilead In Hep C Drug Race
TheStreet.com
Tuesday, April 23, 2013 - 11:21am
tags:
Gilead, Bristol-Myers Squibb, hepatitis C, sofosbuvir, daclatasvir, asunaprevir, BMS-791325

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.